Suchergebnisse - "Miranda, Roberto"

PubPharm (15)

1

High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL

enthalten in: Leukemia | 2023

von Li, S. | Qiu, L. | Xu, J. | +8

2

An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation

enthalten in: Journal of cutaneous pathology | 2020

von Minzenmayer, A. | Miranda, R. | Powell, P. | +1

3

Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome : a case report

enthalten in: British journal of haematology | 2020

von Schmelz, J. | Navsaria, L. | Goswamy, R. | +3

4

Unicentric Castleman disease, hyaline vascular variant, stromal rich, with increased plasma cells and a high level of serum IL-6 : Raising the diagnostic and therapeutic issues

enthalten in: Annals of diagnostic pathology | 2019

von Lyapichev, K. | Sukswai, N. | Strati, P. | +3

5

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

enthalten in: British journal of haematology | 2017

von Chihara, D. | Westin, J. | Miranda, R. | +14

6

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Xu-Monette, Z. | Deng, Q. | Manyam, G. | +31

7

EBV-positive diffuse large B-cell lymphoma of the elderly : 2016 update on diagnosis, risk-stratification, and management

enthalten in: American journal of hematology | 2016

von Castillo, J. | Beltran, B. | Miranda, R. | +3

8

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2015

von Xu-Monette, Z. | Dabaja, B. | Wang, X. | +30

9

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Ok, C. | Li, L. | Xu-Monette, Z. | +27

ErratumIn: Clin Cancer Res. 2014 Sep 15;20(18):4974 Dybaer, Karen [corrected to Dybkaer, Karen]

10

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures : a report from The International DLBCL Rituximab-CHOP Consortium Program

enthalten in: Blood | 2013

von Hu, S. | Xu-Monette, Z. | Tzankov, A. | +34